The Yong Loo Lin School of Medicine at the National University of Singapore (NUS) has announced a landmark research achievement. Working alongside Singapore‑based data‑centre operator DayOne and Australian biocomputing startup Cortical Labs, the research team has built the world’s first biocomputing server‑rack prototype powered by living human neurons, moving wetware‑based computing out of the laboratory and into real‑world data‑centre feasibility trials.
The demonstration rack consists of 20 CL1 biocomputing units. Using induced pluripotent stem‑cell technology, scientists reprogram human somatic cells to generate human brain neurons under laboratory conditions, which are then placed onto microelectrode‑array chips. The system stimulates biological neural networks via electrodes and records neural‑firing signals to accomplish information input, computation and output, establishing an innovative computing architecture distinct from conventional semiconductor chips. In total, around 16 million cultured neurons have been deployed across the prototype cluster.
Unlike traditional GPU server rooms, a biocomputing data centre requires a sophisticated life‑support infrastructure. Facilities must maintain constant temperature, precise control of gas concentrations and culture‑medium pH levels. Technical staff replenish cell‑culture nutrient solutions every three days to keep the neurons viable. Energy‑efficiency performance stands out as one of the technology’s most market‑attractive features: each CL1 unit, including its life‑support module, draws approximately 30 watts, far less than the kilowatt‑scale power consumption of today’s high‑end graphics processors. This gives biocomputing enormous energy‑saving potential for selected artificial‑intelligence workloads.
Professor Rickie Patani, Director of the Neuroscience Programme at the NUS Institute of Molecular and Cell Biology and lead researcher for the project, explained that biological neural networks are not intended to displace silicon‑based chips for heavy‑duty floating‑point calculations. Naturally optimised for few‑shot learning, dynamic environmental adaptation and self‑directed neural‑connection remodelling, living‑neuron computing is well‑suited to niche use‑cases where conventional AI struggles, including drug‑discovery screening, humanoid‑robot sensory control, network‑anomaly monitoring and financial‑fraud detection, functioning as a complementary form of computing resource.
Hon Weng Chong, Chief Executive Officer of Cortical Labs, commented during the results launch that the Singapore demonstration project represents a critical milestone on the road toward biocomputing commercialisation. Under the jointly published technology roadmap, once stability testing at the laboratory stage is complete, the full demonstration setup will be relocated from the NUS campus to a commercial data‑centre campus operated by DayOne for phased cluster expansion. The long‑term objective is to build a commercial biocomputing facility in Singapore housing up to 1,000 CL1 compute units. The current reference price for a single CL1 device stands at USD 35,000.
Industry analysts note that if biocomputing developers can overcome major bottlenecks relating to neuron lifespan, mass manufacturing and standardised operational workflows, Singapore could seize an early‑mover advantage in the emerging low‑energy‑consumption computing sector. Success would be likely to drive cross‑border investment momentum spanning biotechnology, artificial intelligence and green data‑centre development across the Asia‑Pacific region.